Andy | 15 minutes OASIS

What

Andy is an AI-powered and human-reviewed documentation platform for home health organizations. Based on the page, it combines ambient scribing, built-in quality assurance, and PDGM coding support to help clinicians document visits, improve chart quality, and strengthen reimbursement capture.

The product appears positioned for home health agencies that want an easier charting workflow for clinicians and more consistent documentation quality across the organization. Its core workflow is simple: start the app, speak naturally during the visit, and then review the resulting chart in the EHR, with QA and coding support layered into the process.

Features

• Ambient scribing for home health visits — Clinicians can start documentation in two taps and speak naturally during the visit, reducing manual charting effort.
• EHR-based chart review workflow — The page states that Andy charts in the EHR, which suggests clinicians review documentation within their existing record workflow rather than rewriting notes separately.
• Built-in documentation QA — The system helps clinicians produce more complete and survey-ready documentation, including support for complex cases such as multiple wounds or medications.
• Medication list cleanup — Andy is described as generating a cleaner, more patient-friendly medication list, which can improve documentation clarity and handoff quality.
• OASIS-related support — The page highlights accurate M0000 item scoring "where safe," indicating assistance with structured assessment documentation.
• PDGM coding support with human review — Andy combines AI and clinical expert review to support coding and case-mix optimization for care already being delivered.

Helpful Tips

• Validate EHR workflow details early — The site says Andy charts in the EHR and works with major home health EMRs, but it does not specify which systems or how write-back works, so implementation teams should confirm exact workflow and compatibility.
• Use it as a documentation standardization tool — Products like this are often most valuable when agencies want to reduce variation between clinicians, especially across newer staff and experienced field staff with different charting habits.
• Review QA guardrails carefully — Since the page emphasizes "healthy skepticism" and safe scoring, buyers should examine how the product flags uncertainty, exceptions, and clinician review responsibilities.
• Measure both clinician time savings and coding lift — The strongest business case will likely come from a combination of reduced charting burden, improved note completeness, and more accurate PDGM documentation rather than any single metric alone.
• Confirm the human review model — The site mentions clinical expert review, so agencies should clarify which parts of the workflow are AI-generated, which are human-reviewed, and how turnaround expectations fit operational needs.